CoChat

Mass spectrometric determination of early and advanced glycation in biology

Open access
Rabbani, Naila, Ashour, Amal, Thornalley, Paul J · 2016 · Glycoconjugate Journal
Cited by 98

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Protein glycation in biological systems occurs predominantly on lysine, arginine and N-terminal residues of proteins. Major quantitative glycation adducts are found at mean extents of modification of 1-5 mol percent of proteins. These are glucose-derived fructosamine on lysine and N-terminal residues of proteins, methylglyoxal-derived hydroimidazolone on arginine residues and N(ε)-carboxymethyl-lysine residues mainly formed by the oxidative degradation of fructosamine. Total glycation adducts of different types are quantified by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC-MS/MS) in multiple reaction monitoring mode. Metabolism of glycated proteins is followed by LC-MS/MS of glycation free adducts as minor components of the amino acid metabolome. Glycated proteins and sites of modification within them - amino acid residues modified by the glycating agent moiety - are identified and quantified by label-free and stable isotope labelling with amino acids in cell culture (SILAC) high resolution mass spectrometry. Sites of glycation by glucose and methylglyoxal in selected proteins are listed. Key issues in applying proteomics techniques to analysis of glycated proteins are: (i) avoiding compromise of analysis by formation, loss and relocation of glycation adducts in pre-analytic processing; (ii) specificity of immunoaffinity enrichment procedures, (iii) maximizing protein sequence coverage in mass spectrometric analysis for detection of glycation sites, and (iv) development of bioinformatics tools for prediction of protein glycation sites. Protein glycation studies have important applications in biology, ageing and translational medicine - particularly on studies of obesity, diabetes, cardiovascular disease, renal failure, neurological disorders and cancer. Mass spectrometric analysis of glycated proteins has yet to find widespread use clinically. Future use in health screening, disease diagnosis and therapeutic monitoring, and drug and functional food development is expected. A protocol for high resolution mass spectrometry proteomics of glycated proteins is given.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10719-016-9709-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 110

  1. Rabbani N., Thornalley P.J.: Glycation research in amino acids: a place to call home. Amino Acids. 42(4), 1087–1096 (2012) · DOI
  2. Thornalley P.J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., Dawnay A.: Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375(3), 581–592 (2003) · DOI · Paper page
  3. Ahmed N., Argirov O.K., Minhas H.S., Cordeiro C.A., Thornalley P.J.: Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatisation by aminoquinolyl-N-hydroxysuccimidyl-carbamate and application to Nε-carboxymethyl-lysine- and Nε-(1-carboxyethyl)lysine-modified albumin. Biochem. J. 364(1), 1–14 (2002) · DOI · Paper page
  4. Rabbani N., Thornalley P.J.: Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids. 42(4), 1133–1142 (2012) · DOI · Paper page
  5. Baynes J.W., Thorpe S.R., Murtiashaw M.H.: Nonenzymatic glucosylation of lysine residues in albumin. Methods Enzymol. 106, 88–98 (1984) · DOI
  6. Smith P.R., Thornalley P.J.: Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. (Studies with the model fructosamine, N -(1-deoxy-D-fructose-1-yl)hippuryl-lysine). Eur J Biochem. 210(3), 729–739 (1992) · DOI · Paper page
  7. Calvo C., Ulloa N., Campos M., Verdugo C., Ayrault-Jarrier M.: The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo. Clin Chim Acta. 217(2), 193–198 (1993) · doi:10.1016/0009-8981(93)90165-z
  8. Shuvaev V.V., Fujii J., Kawasaki Y., Itoh H., Hamaoka R., Barbier A., Ziegler O., Siest G., Taniguchi N.: Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site. Biochim Biophys Acta. 1454(3), 296–308 (1999) · DOI
  9. Fujita T., Suzuki K., Tada T., Yoshihara Y., Hamaoka R., Uchida K., Matuo Y., Sasaki T., Hanafusa T., Taniguchi N.: Human erythrocyte Bisphosphoglycerate mutase: inactivation by glycation in vivo and in vitro. J Biochem. 124(6), 1237–1244 (1998) · doi:10.1093/oxfordjournals.jbchem.a022243
  10. Acosta J., Hettinga J., Flückiger R., Krumrei N., Goldfine A., Angarita L., Halperin J.: Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A. 97(10), 5450–5455 (2000) · DOI · Paper page
  11. Niemann M.A., Bhown A.S., Miller E.J.: The principal site of glycation of human complement factor B. Biochem J. 274(2), 473–480 (1991) · doi:10.1042/bj2740473
  12. O’Harte F.P.M., Abdel-Wahab Y.H.A., Conlon J.M., Flatt P.R.: Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells. Biochim Biophys Acta. 1425(2), 319–327 (1998) · DOI
  13. O'Harte F.P.M., Abdel-Wahab Y.H.A., Conlon J.M., Flatt P.R.: Glycation of glucagon-like peptide-1(7–36)amide: characterization and impaired action on rat insulin secreting cells. Diabetologia. 41(10), 1187–1193 (1998) · DOI
  14. Zhang X., Medzihradszky K.F., Cunningham J., Lee P.D.K., Rognerud C.L., Ou C.N., Harmatz P., Witkowska H.E.: Characterization of glycated hemoglobin in diabetic patients: usefulness of electrospray mass spectrometry in monitoring the extent and distribution of glycation. J ChromatogrB. 759(1), 1–15 (2001) · DOI
  15. Coletta M., Amiconi G., Bellelli A., Bertollini A., Čarsky J., Castagnola M., Condò S., Brunori M.: Alteration of T-state binding properties of naturally glycated hemoglobin, HbA1c. J Mol Biol. 203(1), 233–239 (1988) · DOI
  16. Wang S.H., Wang T.F., Wu C.H., Chen S.H.: In-depth comparative characterization of hemoglobin glycation in normal and diabetic bloods by LC-MSMS. J Amer Soc Mass Spectrometry. 25(5), 758–766 (2014) · DOI
  17. O'Harte F.P.M., Højrup P., Barnett C.R., Flatt P.R.: Identification of the site of glycation of human insulin. Peptides. 17(8), 1323–1330 (1996) · DOI
  18. Miyata T., Inagi R., Wada Y., Ueda Y., Iida Y., Takahashi M., Taniguchi N., Maeda K.: Glycation of human beta 2 -microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites. Biochemistry. 33(40), 12215–12221 (1994) · DOI
  19. Barnaby O.S., Cerny R.L., Clarke W., Hage D.S.: Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI–TOF MS. Clin Chim Acta. 412(17–18), 1606–1615 (2011) · DOI
  20. Rabbani N., AntonySunil A., Rossing K., Rossing P., Tarnow L., Parving H.H., Thornalley P.J.: Effect of Irbesartan treatment on plasma and urinary protein glycation, oxidation and nitration markers in patients with type 2 diabetes and microalbuminuria. Amino Acids. 42(5), 1627–1639 (2011) · DOI
  21. Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K., Taniguchi N.: Glycation and inactivation of human Cu-Zn-superoxide dismutase - identification of the invitro glycated sites. J Biol Chem. 262(35), 16969–16972 (1987) · DOI · Paper page
  22. Abraham E.C., Cherian M., Smith J.B.: Site selectivity in the glycation of αA-crystallin and αB-Crystallins by glucose. Biochem Biophys Res Commun. 201(3), 1451–1456 (1994) · doi:10.1006/bbrc.1994.1866
  23. Casey E.B., Zhao H.R., Abraham E.C.: Role of glycine 1 and lysine 2 in the glycation of bovine g B-crystallin. J.Biol.Chem. 270(35), 20781–20786 (1995) · doi:10.1074/jbc.270.35.20781
  24. Baldwin J.S., Lee L., Leung T.K., Muruganandam A., Mutus B.: Identification of the site of nonenzymatic glycation of glutathione-peroxidase - rationalization of the glycation-related catalytic alterations on the basis of 3-dimensional protein-structure. Biochim Biophys Acta. 1247(1), 60–64 (1995) · doi:10.1016/0167-4838(94)00202-r
  25. Guedes S., Vitorino R., Domingues M.R.M., Amado F., Domingues P.: Mass spectrometry characterization of the glycation sites of bovine insulin by tandem mass spectrometry. J Am Soc Mass Spectrom. 20(7), 1319–1326 (2009) · DOI
  26. Swamy Mruthinti S., Schey K.L.: Mass spectroscopic identification of in vitro glycated sites of MIP. Curr Eye Res. 16(9), 936–941 (1997) · doi:10.1076/ceyr.16.9.936.5037
  27. Watkins N.G., Thorpe S.R., Baynes J.W.: Glycation of amino groups in protein. (Studies on the specificity of modification of RNase by glucose). J Biol Chem. 260(19), 10629–10636 (1985) · DOI · Paper page
  28. Frolov A., Hoffmann P., Hoffmann R.: Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. J Mass Spectrom. 41(11), 1459–1469 (2006) · DOI
  29. Reiser K.M., Amigable M., Last J.A.: Nonenzymatic glycation of type I collagen (the effects of aging on preferential glycation sites. J.Biol.Chem. 267(34), 24207–24216 (1992) · DOI
  30. Takahashi M., Lu Y.-b., Myint T., Fujii J., Wada Y., Taniguchi N.: In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification of glycation sites. Biochemistry. 34(4), 1433–1438 (1995) · DOI
  31. Ahmed M.U., Thorpe S.R., Baynes J.W.: Identification of Nε-carboxymethyl-lysine as a degradation product of fructoselysine in glycated protein. J Biol Chem. 261(11), 4889–4894 (1986) · DOI · Paper page
  32. Wells-Knecht M.C., Thorpe S.R., Baynes J.W.: Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34(46), 15134–15141 (1995) · DOI · Paper page
  33. Anderson M.M., Requena J.R., Crowley J.R., Thorpe S.R., Heinecke J.W.: The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest. 104(1), 103–113 (1999) · DOI · Paper page
  34. Ahmed N., Babaei-Jadidi R., Howell S.K., Beisswenger P.J., Thornalley P.J.: Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia. 48(8), 1590–1603 (2005) · DOI · Paper page
  35. Babaei-Jadidi R., Karachalias N., Kupich C., Ahmed N., Thornalley P.J.: High dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia. 47, 2235–2246 (2004) · DOI
  36. Karachalias N., Babaei-Jadidi R., Rabbani N., Thornalley P.J.: Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia. 53(7), 1506–1516 (2010) · DOI
  37. Ahmed N., Thornalley P.J., Dawczynski J., Franke S., Strobel J., Stein G., Haik Jr. G.M.: Methylglyoxal-derived hydroimidazolone advanced glycation endproducts of human lens proteins. Investig Ophthalmol Vis Sci. 44(12), 5287–5292 (2003) · DOI · Paper page
  38. Lo T.W.C., Selwood T., Thornalley P.J.: Reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol. 48(10), 1865–1870 (1994) · DOI
  39. Gallet X., Charloteaux B., Thomas A., Braseur R.: A fast method to predict protein interaction sites from sequences. JMolBiol. 302(4), 917–926 (2000)
  40. Godfrey L., Yamada-Fowler N., Smith J.A., Thornalley P.J., Rabbani N.: Arginine-directed glycation and decreased HDL plasma concentration and functionality. Nutrition and diabetes. 4, e134 (2014) · DOI · Paper page
  41. Rabbani N., Godfrey L., Xue M., Shaheen F., Geoffrion M., Milne R., Thornalley P.J.: Conversion of low density lipoprotein to the pro-atherogenic form by methylglyoxal with increased arterial proteoglycan binding and aortal retention. Diabetes. 60(7), 1973–1980 (2011) · DOI · Paper page
  42. Dobler D., Ahmed N., Song L.J., Eboigbodin K.E., Thornalley P.J.: Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes. 55(7), 1961–1969 (2006) · DOI · Paper page
  43. Pedchenko V.K., Chetyrkin S.V., Chuang P., Ham A.J., Saleem M.A., Mathieson P.W., Hudson B.G., Voziyan P.A.: Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes. 54(10), 2952–2960 (2005) · DOI · Paper page
  44. Gangadhariah M.H., Wang B.L., Linetsky M., Henning C., Spanneberg R., Glomb M.A., Nagaraj R.H.: Hydroimidazolone modification of human alpha A-crystallin: effect on the chaperone function and protein refolding ability. Biochim Biophys Acta. 1802(4), 432–441 (2010) · DOI
  45. Kiselar J.G., Wang X., Dubyak G.R., El Sanadi C., Ghosh S.K., Lundberg K., Williams W.M.: Modification of β-Defensin-2 by Dicarbonyls methylglyoxal and glyoxal inhibits antibacterial and chemotactic function in vitro. PLoS One. 10(8), e0130533 (2015) · DOI
  46. Lund T., Svindland A., Pepaj M., Jensen A.B., Berg J.P., Kilhovd B., Hanssen K.F.: Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans. Diabetes Vascular Disease Research. 8(4), 284–294 (2011) · DOI
  47. Oya-Ito T., Naito Y., Takagi T., Handa O., Matsui H., Yamada M., Shima K., Yoshikawa T.: Heat-shock protein 27 (Hsp27) as a target of methylglyoxal in gastrointestinal cancer. Biochim Biophys Acta. 1812(7), 769–781 (2011) · DOI
  48. Chen Y., Ahmed N., Thornalley P.J.: Peptide mapping of human hemoglobin modified minimally by methylglyoxal in vitro. AnnNYAcadSci. 1043, 905 (2005) · doi:10.1196/annals.1333.119
  49. Gao Y., Wang Y.: Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal. Biochemistry. 45(51), 15654–15660 (2006) · DOI
  50. Thangarajah H., Yao D.C., Chang E.I., Shi Y.B., Jazayeri L., Vial I.N., Galiano R.D., Du X.L., Grogan R., Galvez M.G., Januszyk M., Brownlee M., Gurtner G.C.: The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A. 106(32), 13505–13510 (2009) · DOI · Paper page
  51. Oliveira L., Lages A., Gomes R., Neves H., Familia C., Coelho A., Quintas A.: Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation. BMC Biochem. 12(1), 41 (2011) · DOI
  52. Chumsae C., Gifford K., Lian W., Liu H., Radziejewski C.H., Zhou Z.S.: Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species. Anal Chem. 85(23), 11401–11409 (2013) · DOI
  53. Kinsky O.R.: Dicarbonyl Protein Adduction: Plasminogen as a Target and Metformin as a Scavenging Therapeutic in Type 2 Diabetes. PhD thesis. PhD thesis. University of Arizona, Tucson, USA (2014)
  54. Queisser M.A., Yao D., Geisler S., Hammes H.P., Lochnit G., Schleicher E.D., Brownlee M., Preissner K.T.: Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes. 59(3), 670–678 (2010) · DOI · Paper page
  55. Brock J.W.C., Cotham W.E., Thorpe S.R., Baynes J.W., Ames J.M.: Detection and identification of arginine modifications on methylglyoxal-modified ribonuclease by mass spectrometric analysis. J Mass Spectrom. 42(1), 89–100 (2007) · DOI · Paper page
  56. Cotham W.E., Metz T.O., Ferguson P.L., Brock J.W.C., Hinton D.J.S., Thorpe S.R., Baynes J.W., Ames J.M.: Proteomic analysis of arginine adducts on glyoxal-modified ribonuclease. Mol Cell Proteomics. 3(12), 1145–1153 (2004) · DOI
  57. Kimzey, M.J., Yassine, H.N., Riepel, B.M., Tsaprailis, G., Monks, T.J., Lau, S.S.: New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. Chem Biol Interact 192(1–2), 122–128 (2011). · DOI
  58. Ahmed N., Dobler D., Dean M., Thornalley P.J.: Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J. Biol. Chem. 280(7), 5724–5732 (2005) · DOI · Paper page
  59. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., Suske G., Rabbani N., Thornalley P.J., Sarthy V.P., Hammes H.P., Brownlee M.: High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 282(42), 31038–31045 (2007) · DOI · Paper page
  60. Agalou S., Ahmed N., Babaei-Jadidi R., Dawnay A., Thornalley P.J.: Profound mishandling of protein glycation degradation products in uremia and dialysis. J Amer Soc Nephrol. 16(5), 1471–1485 (2005) · DOI · Paper page
  61. Teerlink T., Barto R., ten Brink H.J., Schalkwijk C.G.: Measurement of Nî-(carboxymethyl)lysine and Nî-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clin Chem. 50(7), 1222–1228 (2004) · DOI · Paper page
  62. Rabbani N., Shaheen F., Anwar A., Masania J., Thornalley P.J.: Assay of methylglyoxal-derived protein and nucleotide AGEs. Biochem Soc Trans. 42(2), 511–517 (2014) · DOI · Paper page
  63. Fan X., Sell D.R., Zhang J., Nemet I., Theves M., Lu J., Strauch C., Halushka M.K., Monnier V.M.: Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: a comparative analysis. Free Radic Biol Med. 49(5), 847–856 (2010) · DOI · Paper page
  64. Henle T., Walter H., Klostermeyer H.: Evaluation of the extent of the early Maillard-reaction in milk products by direct measurement of the Amadori-product lactuloselysine. ZLebensmUntersForsch. 193, 119–122 (1991)
  65. Rabbani N., Varma Chittari M., Bodmer C.W., Zehnder D., Ceriello A., Thornalley P.J.: Increased glycation and oxidative damage to apolipoprotein B100 of LDL in patients with type 2 diabetes and effect of metformin. Diabetes. 59(4), 1038–1045 (2010) · DOI · Paper page
  66. Ahmed N., Thornalley P.J.: Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatisation with aminoquinolyl-N-hydroxysuccimidyl-carbamate and intrinsic fluorescence. Biochem J. 364, 15–24 (2002) · DOI · Paper page
  67. Glomb M.A., Pfahler C.: Amides are novel protein modifications formed by physiological sugars. J Biol Chem. 276(45), 41638–41647 (2001) · DOI · Paper page
  68. Scheffer P.G., Bakker S.J.L., Heine R.J., Teerlink T.: Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography. Clin Chem. 43(10), 1904–1912 (1997) · DOI
  69. Krause R., Knoll K., Henle T.: Studies on the formation of furosine and pyridosine during acid hydrolysis of different Amadori products of lysine. Eur Food Res Technol. 216(4), 277–283 (2003) · DOI
  70. Troise A.D., Fiore A., Wiltafsky M., Fogliano V.: Quantification of N epsilon-(2-furoylmethyl)-L-lysine (furosine), N epsilon-(carboxymethyl)-L-lysine (CML), N epsilon-(carboxyethyl)-L-lysine (CEL) and total lysine through stable isotope dilution assay and tandem mass spectrometry. Food Chem. 188, 357–364 (2015) · DOI
  71. Gupta N., Pevzner P.A.: False discovery rates of protein identifications: a strike against the two-peptide rule. J Proteome Res. 8(9), 4173–4181 (2009) · DOI · Paper page
  72. Ong S.-E., Mann M.: A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc. 1(6), 2650–2660 (2007) · DOI · Paper page
  73. Noirel J., Evans C., Salim M., Mukherjee J., Ow S.Y., Pandhal J., Pham T.K., Biggs C.A., Wright P.C.: Methods in quantitative proteomics: setting iTRAQ on the right track. Curr Probl Dermatol. 8(1), 17–30 (2011)
  74. Nahnsen S., Bielow C., Reinert K., Kohlbacher O.: Tools for label-free peptide quantification. Mol Cell Proteomics. 12(3), 549–556 (2013) · DOI · Paper page
  75. Kimzey M.J., Kinsky O.R., Yassine H.N., Tsaprailis G., Stump C.S., Monks T.J., Lau S.S.: Site specific modification of the human plasma proteome by methylglyoxal. Toxicol Appl Pharmacol. 289(2), 155–162 (2015) · DOI
  76. Brede C., Hop B., Jørgensen K., Skadberg Ø.: Measurement of glycated albumin in serum and plasma by LC-MS/MS. Scand J Clin Lab Invest. 76(3), 195–201 (2016) · DOI
  77. Liebler D.C., Zimmerman L.J.: Targeted quantitation of proteins by mass spectrometry. Biochemistry. 52(22), 3797–3806 (2013) · DOI · Paper page
  78. Nagaraj N., Kulak N.A., Cox J., Neuhauser N., Mayr K., Hoerning O., Vorm O., Mann M.: System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap. Mol Cell Proteomics. 11(3), 11 (2012) · DOI · Paper page
  79. Meyer J.G.: In silico proteome cleavage reveals iterative digestion strategy for high sequence coverage. ISRN Computational Biol. 2014, 7 (2014) · DOI
  80. Johansen M.B., Kiemer L., Brunak S.: Analysis and prediction of mammalian protein glycation. Glycobiology. 16(9), 844–853 (2006) · DOI · Paper page
  81. Zhang Q., Monroe M.E., Schepmoes A.A., Clauss T.R.W., Gritsenko M.A., Meng D., Petyuk V.A., Smith R.D., Metz T.O.: Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. J Proteome Res. 10(7), 3076–3088 (2011) · DOI
  82. Anandakrishnan R., Aguilar B., Onufriev A.V.: H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 40(W1), W537–W541 (2012) · DOI · Paper page
  83. Harris R., Patel S.U., Sadler P.J., Viles J.H.: Observation of albumin resonances in proton nuclear magnetic resonance spectra of human blood plasma: N-terminal assignments aided by use of modified recombinant albumin. Analyst. 121(7), 913–922 (1996) · doi:10.1039/an9962100913
  84. Venkatraman J., Aggarwal K., Balaram P.: Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. Chem Biol. 8(7), 611–625 (2001) · DOI
  85. Schleicher E., Wieland O.H.: Kinetic analysis of glycation as a tool for assesing the half-life of proteins. Biochim Biophys Acta. 884(1), 199–205 (1986) · DOI
  86. Wang Y., Yu H., Shi X., Luo Z., Lin D., Huang M.: Structural mechanism of ring-opening reaction of glucose by human serum albumin. J Biol Chem. 288(22), 15980–15987 (2013) · DOI
  87. Delpierre G., Rider M.H., Collard F., Stroobant V., Vanstapel F., Santos H., Van Schaftingen E.: Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes. 49(10), 1627–1634 (2000) · DOI · Paper page
  88. Delpierre G., Vertommen D., Communi D., Rider M.H., Van Schaftingen E.: Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin. J. Biol. Chem. 279(26), 27613–27620 (2004) · DOI · Paper page
  89. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R.: A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 75(17), 4646–4658 (2003) · DOI · Paper page
  90. Roberts N.B., Amara A.B., Morris M., Green B.N.: Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated hemoglobin. Clin Chem. 47(2), 316–321 (2001) · DOI
  91. Thornalley P.J., Argirova M., Ahmed N., Mann V.M., Argirov O.K., Dawnay A.: Mass spectrometric monitoring of albumin in uraemia. Kidney Int. 58(5), 2228–2234 (2000) · DOI
  92. Jerić I., Versluis C., Horvat Š., Heck A.J.R.: Tracing glycoprotein structures: electrospray ionization tandem mass spectrometric analysis of sugar–peptide adducts. J Mass Spectrom. 37(8), 803–811 (2002) · DOI
  93. Horvat Š., Jakas A.: Peptide and amino acid glycation: new insights into the Maillard reaction. J Pept Sci. 10(3), 119–137 (2004) · DOI
  94. Mennella C., Visciano M., Napolitano A., Del Castillo M.D., Fogliano V.: Glycation of lysine-containing dipeptides. J Pept Sci. 12(4), 291–296 (2006) · DOI
  95. Zhang Q.B., Frolov A., Tang N., Hoffmann R., van de Goor T., Metz T.O., Smith R.D.: Application of electron transfer dissociation mass spectrometry in analyses of non-enzymatically glycated peptides. Rapid Commun Mass Spectrom. 21(5), 661–666 (2007) · DOI
  96. Cai J., Hurst H.E.: Identification and quantitation of N-(carboxymethyl)valine adducts in hemoglobin by gas chromatography/mass spectrometry. J Mass Spectrom. 34(5), 537–543 (1999) · DOI
  97. Brock J.W.C., Hinton D.J.S., Cotham W.E., Metz T.O., Thorpe S.R., Baynes J.W., Ames J.M.: Proteomic analysis of the site specificity of glycation and Carboxymethylation of ribonuclease. J Proteome Res. 2(5), 506–513 (2003) · DOI · Paper page
  98. Zhang Q., Tang N., Brock J.W.C., Mottaz H.M., Ames J.M., Baynes J.W., Smith R.D., Metz T.O.: Enrichment and analysis of Nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry. J Proteome Res. 6(6), 2323–2330 (2007) · DOI · Paper page
  99. Myint T., Hoshi S., Ookawara T., Miyazawa N., Keiichiro M., Suzuki K., Taniguchi N.: Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG. Biochim Biophys Acta. 1272, 73–79 (1995) · DOI
  100. Thornalley P.J., Langborg A., Minhas H.S.: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 344(1), 109–116 (1999) · DOI · Paper page
  101. Smith P.R., Thornalley P.J.: Influence of pH and phosphate ions on the kinetics of enolisation and degradation of fructosamines. Studies with the model fructosamine, Nε-1-deoxy-D-fructos-1-yl hippuryllysine. Biochem Internat. 28(3), 429–439 (1992)
  102. Hustoft H.K., Reubsaet L., Greibrokk T., Lundanes E., Malerod H.: Critical assessment of accelerating trypsination methods. J Pharm Biomed Anal. 56(5), 1069–1078 (2011) · doi:10.1016/j.jpba.2011.08.013
  103. Schmidt R., Böhme D., Singer D., Frolov A.: Specific tandem mass spectrometric detection of AGE-modified arginine residues in peptides. J Mass Spectrom. 50(3), 613–624 (2015) · DOI
  104. Rabbani N., Thornalley P.J.: Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples. Nat Protoc. 9(8), 1969–1979 (2014) · DOI · Paper page
  105. Lo T.W.C., Westwood M.E., McLellan A.C., Selwood T., Thornalley P.J.: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine, Nα-acetyl-lysine, and bovine serum albumin. J Biol Chem. 269(51), 32299–32305 (1994) · DOI · Paper page
  106. Leitner A., Lindner W.: Functional probing of arginine residues in proteins using mass spectrometry and an arginine-specific covalent tagging concept. Anal Chem. 77(14), 4481–4488 (2005) · DOI
  107. Leitner A., Amon S., Rizzi A., Lindner W.: Use of the arginine-specific butanedione/phenylboronic acid tag for analysis of peptides and protein digests using matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 21(7), 1321–1330 (2007) · doi:10.1002/rcm.2967
  108. Kilhovd B.K., Giardino I., Torjesen P.A., Birkeland K.I., Berg T.J., Thornalley P.J., Brownlee M., Hanssen K.F.: Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 52(2), 163–167 (2003) · DOI · Paper page
  109. Biemel K.M., Friedl D.A., Lederer M.O.: Identification and quantification of major Maillard cross-links in human serum albumin and lens protein - evidence for glucosepane as the dominant compound. J Biol Chem. 277(28), 24907–24915 (2002) · DOI · Paper page
  110. Dai Z., Wang B., Sun G., Fan X., Anderson V.E., Monnier V.M.: Identification of glucose-derived cross-linking sites in ribonuclease a. J Proteome Res. 7(7), 2756–2768 (2008) · DOI

Cited by

See all 98

Metadata

Authors
Rabbani, N., Ashour, A., & Thornalley, P. J.
Venue
Glycoconjugate Journal
Published
2016-07-20
Volume
33
Issue
4
Pages
553-568
ISSN
  • 0282-0080 (ISSN-L)
  • 1573-4986
OpenAlex
W2470810595
Cited by
98
References
5
FWCI
7.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mass spectrometric determination of early and advanced glycation in biology. https://app.cochat.ai/papers/10.1007/s10719-016-9709-8
The paper
Rabbani, N., Ashour, A., & Thornalley, P. J. (2016). Mass spectrometric determination of early and advanced glycation in biology. Glycoconjugate Journal. https://doi.org/10.1007/s10719-016-9709-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.